Chromatin Immunoprecipitation sequencing (ChIP-Seq) determines DNA binding sites for particular proteins on a genome. Chromatin Immunoprecipitation assays have the ability to capture an image of specific protein to DNA interactions that are occurring in a system and process these interactions using quantitative polymerase chain reaction (qPCR), ChIP-chip, or next generation sequencing (NGS). When paired with […]
Introduction Eradication and prevention of infectious diseases are achieved most often via vaccination. The common or traditional vaccines are made using the actual pathogen material, such as modified live or killed (inactivated) viruses. The use of these types of vaccines is sometimes associated with serious side effects. For some infectious agents, it is often difficult […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.
inquiry@nullpsomagen.com
(301) 251-1007
ROCKVILLE, MARYLAND (HQ)
CLIA: 21D2062464 | CAP: 8742212
BROOKLYN, NEW YORK
CAMBRIDGE, MASSACHUSETTS
STERLING, VIRGINIA
CLIA: 49D2172599
KOSDAQ: PSOMAGEN INC (950200)